Position
Fidelity in Trevi Therapeutics, Inc.
Back to the book · All holders of TRVI
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $54M$11.93 → $18.65
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.5M | $81.4M | — | — | — | 0.0% |
| Q1 2026 | 8.04M | $95.9M | $11.93 | −$3.84M | $18.3M | 0.0% |
| Q2 2026 | 12.6M | $234.3M | $18.65 | $54M | $84.4M | 0.0% |